PDF herunterladen
Clin Colon Rectal Surg
DOI: 10.1055/s-0044-1786377
Review Article

How to Approach the Difficult Perineum in Crohn's Disease

Emily Rinebold
1   Division of Colon and Rectal Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York
,
Alex L. Huang
1   Division of Colon and Rectal Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York
,
Sue J. Hahn
1   Division of Colon and Rectal Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Crohn's disease (CD) is a chronic, inflammatory bowel disease with a wide range of presentations, including perianal disease. Presentation is variable, ranging from skin tags to complex fistulas, strictures, and nonhealing wounds. Symptoms of perianal CD can be devastating and may impact quality of life. Optimal management requires coordinated medical and surgical therapy. When possible, conservative treatment of perianal disease should be attempted. However, surgical treatment is often required, and some patients may ultimately require total proctocolectomy with permanent diversion due to the severity of disease. Even with close attention and treatment, disease can be recurrent, and complications of treatment are sometimes worse than the initial presentation. Novel treatments, including use of mesenchymal stem cells and autologous fat grafting, hold some promise, but are not yet widely available. Thorough knowledge of treatment options, careful patient selection, coordination between medical and surgical providers, and setting realistic expectations are important in the successful treatment of difficult perineal CD.

Keywords

Crohn's disease - fistulizing Crohn's disease - perianal fistula - nonhealing perineal wound - proctectomy


Publikationsverlauf

Artikel online veröffentlicht:
07. Mai 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Brochard C, Rabilloud ML, Hamonic S. et al; Groupe ABERMAD. Natural history of perianal Crohn's disease: long-term follow-up of a population-based cohort. Clin Gastroenterol Hepatol 2022; 20 (02) e102-e110
    CrossrefPubMedGoogle Scholar
  • 2 Schwartz DA, Loftus Jr EV, Tremaine WJ. et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122 (04) 875-880
    CrossrefPubMedGoogle Scholar
  • 3 Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. Epidemiology and natural history of perianal Crohn's disease: a systematic review and meta-analysis of population-based cohorts. Inflamm Bowel Dis 2022; 28 (10) 1477-1484
    CrossrefPubMedGoogle Scholar
  • 4 Tjandra D, Garg M, Behrenbruch C. et al. Review article: investigation and management of internal fistulae in Crohn's disease. Aliment Pharmacol Ther 2021; 53 (10) 1064-1079
    CrossrefPubMedGoogle Scholar
  • 5 Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RC, Kamm MA. The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther 2003; 17 (09) 1145-1151
    CrossrefPubMedGoogle Scholar
  • 6 Singh B, McC Mortensen NJ, Jewell DP, George B. Perianal Crohn's disease. Br J Surg 2004; 91 (07) 801-814
    CrossrefPubMedGoogle Scholar
  • 7 Yamamoto T, Allan RN, Keighley MR. Audit of single-stage proctocolectomy for Crohn's disease: postoperative complications and recurrence. Dis Colon Rectum 2000; 43 (02) 249-256
    CrossrefPubMedGoogle Scholar
  • 8 Cushing K, Higgins PDR. Management of Crohn disease: a review. JAMA 2021; 325 (01) 69-80
    CrossrefPubMedGoogle Scholar
  • 9 Feuerstein JD, Ho EY, Shmidt E. et al; American Gastroenterological Association Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn's disease. Gastroenterology 2021; 160 (07) 2496-2508
    CrossrefPubMedGoogle Scholar
  • 10 Lee MJ, Parker CE, Taylor SR. et al. Efficacy of medical therapies for fistulizing Crohn's disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018; 16 (12) 1879-1892
    CrossrefPubMedGoogle Scholar
  • 11 Colombel JF, Sandborn WJ, Rutgeerts P. et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007; 132 (01) 52-65
    CrossrefPubMedGoogle Scholar
  • 12 Godoy Brewer GM, Salem G, Afzal MA. et al. Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis. BMJ Open Gastroenterol 2021; 8 (01) 8
    CrossrefPubMedGoogle Scholar
  • 13 Ayoub F, Odenwald M, Micic D. et al. Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis. Intest Res 2022; 20 (02) 240-250
    CrossrefPubMedGoogle Scholar
  • 14 Genua JC, Vivas DA. Management of nonhealing perineal wounds. Clin Colon Rectal Surg 2007; 20 (04) 322-328
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 15 Mosli MH, Zou G, Garg SK. et al. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol 2015; 110 (06) 802-819 , quiz 820
    CrossrefPubMedGoogle Scholar
  • 16 Wetwittayakhlang P, Albader F, Golovics PA. et al. Clinical outcomes of COVID-19 and impact on disease course in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol 2021; 2021: 7591141
    CrossrefPubMedGoogle Scholar
  • 17 Steinhagen E, Bafford AC. Anorectal Crohn's Disease. In: Steele SR, Hull TR, Hyman N, Maykel JA, Read TE, Witlow CB. eds. The ASCRS Textbook of Colon and Rectal Surgery. 4th ed.. 2022. . Accessed November 12, 2023 at: https://www.ascrsu.com/ascrs/view/ASCRS-Textbook-of-Colon-and-Rectal-Surgery/2285042/all/Anorectal_Crohn's_Disease
    Google Scholar
  • 18 Gaertner WB, Burgess PL, Davids JS. et al; Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of anorectal abscess, fistula-in-ano, and rectovaginal fistula. Dis Colon Rectum 2022; 65 (08) 964-985
    CrossrefPubMedGoogle Scholar
  • 19 Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn's disease. Gastroenterology 2003; 125 (05) 1508-1530
    CrossrefPubMedGoogle Scholar
  • 20 Makowiec F, Jehle EC, Starlinger M. Clinical course of perianal fistulas in Crohn's disease. Gut 1995; 37 (05) 696-701
    CrossrefPubMedGoogle Scholar
  • 21 Aguilera-Castro L, Ferre-Aracil C, Garcia-Garcia-de-Paredes A, Rodriguez-de-Santiago E, Lopez-Sanroman A. Management of complex perianal Crohn's disease. Ann Gastroenterol 2017; 30 (01) 33-44
    PubMedGoogle Scholar
  • 22 Molendijk I, Nuij VJ, van der Meulen-de Jong AE, van der Woude CJ. Disappointing durable remission rates in complex Crohn's disease fistula. Inflamm Bowel Dis 2014; 20 (11) 2022-2028
    CrossrefPubMedGoogle Scholar
  • 23 Coremans G, Dockx S, Wyndaele J, Hendrickx A. Do anal fistulas in Crohn's disease behave differently and defy Goodsall's rule more frequently than fistulas that are cryptoglandular in origin?. Am J Gastroenterol 2003; 98 (12) 2732-2735
    CrossrefPubMedGoogle Scholar
  • 24 Gallego JC, Echarri A. Role of magnetic resonance imaging in the management of perianal Crohn's disease. Insights Imaging 2018; 9 (01) 47-58
    CrossrefPubMedGoogle Scholar
  • 25 Van Assche G, Dignass A, Reinisch W. et al; European Crohn's and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohn's Colitis 2010; 4 (01) 63-101
    CrossrefPubMedGoogle Scholar
  • 26 West RL, van der Woude CJ, Hansen BE. et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004; 20 (11–12): 1329-1336
    CrossrefPubMedGoogle Scholar
  • 27 Su JW, Ma JJ, Zhang HJ. Use of antibiotics in patients with Crohn's disease: a systematic review and meta-analysis. J Dig Dis 2015; 16 (02) 58-66
    CrossrefPubMedGoogle Scholar
  • 28 Huang J, Liao C, Wu L, Cao Y, Gao F. A meta-analysis of randomized controlled trials comparing antibacterial therapy with placebo in Crohn's disease. Colorectal Dis 2011; 13 (06) 617-626
    CrossrefPubMedGoogle Scholar
  • 29 Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus Jr EV. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology 2010; 139 (04) 1147-1155
    CrossrefPubMedGoogle Scholar
  • 30 Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment Pharmacol Ther 2003; 18 (11–12): 1113-1120
    CrossrefPubMedGoogle Scholar
  • 31 Steinhart AH, Panaccione R, Targownik L. et al. Clinical practice guideline for the medical management of perianal fistulizing Crohn's disease: The Toronto Consensus. Inflamm Bowel Dis 2019; 25 (01) 1-13
    CrossrefPubMedGoogle Scholar
  • 32 Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123 (02) 132-142
    CrossrefPubMedGoogle Scholar
  • 33 Lecomte T, Contou JF, Beaugerie L. et al. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine. Dis Colon Rectum 2003; 46 (11) 1469-1475
    CrossrefPubMedGoogle Scholar
  • 34 Sandborn WJ, Present DH, Isaacs KL. et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003; 125 (02) 380-388
    CrossrefPubMedGoogle Scholar
  • 35 Cat H, Sophani I, Lemann M, Modiglani R, Solue JC. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease. Turk J Gastroenterol 2003; 14 (02) 121-127
    PubMedGoogle Scholar
  • 36 Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994; 39 (02) 374-380
    CrossrefPubMedGoogle Scholar
  • 37 Present DH, Rutgeerts P, Targan S. et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340 (18) 1398-1405
    CrossrefPubMedGoogle Scholar
  • 38 Sands BE, Anderson FH, Bernstein CN. et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350 (09) 876-885
    CrossrefPubMedGoogle Scholar
  • 39 Colombel JF, Schwartz DA, Sandborn WJ. et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009; 58 (07) 940-948
    CrossrefPubMedGoogle Scholar
  • 40 Feagan BG, Schwartz D, Danese S. et al. Efficacy of vedolizumab in fistulising Crohn's disease: exploratory analyses of data from GEMINI 2. J Crohn's Colitis 2018; 12 (05) 621-626
    CrossrefPubMedGoogle Scholar
  • 41 Sandborn WJ, Feagan BG, Rutgeerts P. et al; GEMINI 2 Study Group. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med 2013; 369 (08) 711-721
    CrossrefPubMedGoogle Scholar
  • 42 Regueiro MD, Greer JB, Binion DG. et al; IBD LIVE Physician Group. The inflammatory bowel disease live interinstitutional and interdisciplinary videoconference education (IBD LIVE) series. Inflamm Bowel Dis 2014; 20 (10) 1687-1695
    CrossrefPubMedGoogle Scholar
  • 43 Lozynskyy YS. Treatment algorithms in the case of perianal complications of Crohn's disease. Dig Dis 2009; 27 (04) 565-570
    CrossrefPubMedGoogle Scholar
  • 44 de Groof EJ, Sahami S, Lucas C, Ponsioen CY, Bemelman WA, Buskens CJ. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Colorectal Dis 2016; 18 (07) 667-675
    CrossrefPubMedGoogle Scholar
  • 45 Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006; 49 (12) 1837-1841
    CrossrefPubMedGoogle Scholar
  • 46 Bouguen G, Siproudhis L, Gizard E. et al. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin Gastroenterol Hepatol 2013; 11 (08) 975-81.e1 , 4
    CrossrefPubMedGoogle Scholar
  • 47 Marchesa P, Hull TL, Fazio VW. Advancement sleeve flaps for treatment of severe perianal Crohn's disease. Br J Surg 1998; 85 (12) 1695-1698
    CrossrefPubMedGoogle Scholar
  • 48 Sordo-Mejia R, Gaertner WB. Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease. World J Gastrointest Pathophysiol 2014; 5 (03) 239-251
    CrossrefPubMedGoogle Scholar
  • 49 Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano. Dis Colon Rectum 2010; 53 (04) 486-495
    CrossrefPubMedGoogle Scholar
  • 50 Gingold DS, Murrell ZA, Fleshner PR. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn's disease. Ann Surg 2014; 260 (06) 1057-1061
    CrossrefPubMedGoogle Scholar
  • 51 Kamiński JP, Zaghiyan K, Fleshner P. Increasing experience of ligation of the intersphincteric fistula tract for patients with Crohn's disease: what have we learned?. Colorectal Dis 2017; 19 (08) 750-755
    CrossrefPubMedGoogle Scholar
  • 52 Stellingwerf ME, van Praag EM, Tozer PJ, Bemelman WA, Buskens CJ. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas. BJS Open 2019; 3 (03) 231-241
    CrossrefPubMedGoogle Scholar
  • 53 Senéjoux A, Siproudhis L, Abramowitz L. et al; Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif [GETAID]. Fistula plug in fistulising ano-perineal Crohn's disease: a randomised controlled trial. J Crohn's Colitis 2016; 10 (02) 141-148
    CrossrefPubMedGoogle Scholar
  • 54 Adegbola SO, Sahnan K, Tozer PJ. et al. Symptom amelioration in Crohn's perianal fistulas using Video-assisted Anal Fistula Treatment (VAAFT). J Crohn's Colitis 2018; 12 (09) 1067-1072
    PubMedGoogle Scholar
  • 55 Wilhelm A, Fiebig A, Krawczak M. Five years of experience with the FiLaC™ laser for fistula-in-ano management: long-term follow-up from a single institution. Tech Coloproctol 2017; 21 (04) 269-276
    CrossrefPubMedGoogle Scholar
  • 56 Garcia-Olmo D, Gilaberte I, Binek M. et al. Follow-up study to evaluate the long-term safety and efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in patients with perianal fistulizing Crohn's disease: ADMIRE-CD Phase 3 randomized controlled trial. Dis Colon Rectum 2022; 65 (05) 713-720
    CrossrefPubMedGoogle Scholar
  • 57 Panés J, García-Olmo D, Van Assche G. et al; ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 2016; 388 (10051): 1281-1290
    CrossrefPubMedGoogle Scholar
  • 58 de la Portilla F, Alba F, García-Olmo D, Herrerías JM, González FX, Galindo A. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis 2013; 28 (03) 313-323
    CrossrefPubMedGoogle Scholar
  • 59 Lightner AL, Reese J, Ream J. et al. A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of perianal fistulizing Crohn's disease. Dis Colon Rectum 2023; 66 (10) 1359-1372
    CrossrefPubMedGoogle Scholar
  • 60 Lightner AL, Reese J, Ream J. et al. A phase IB/IIA study of allogeneic, bone marrow-derived, mesenchymal stem cells for the treatment of refractory ileal-anal anastomosis and peripouch fistulas in the setting of Crohn's disease of the pouch. J Crohn's Colitis 2023; 17 (04) 480-488
    CrossrefPubMedGoogle Scholar
  • 61 Lightner AL, Reese JS, Ream J. et al. A phase IB/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn's disease. Surgery 2024; 175 (02) 242-249
    CrossrefPubMedGoogle Scholar
  • 62 Huang EY, Zhao B, Llaneras J. et al. autologous fat grafting: an emerging treatment option for complex anal fistulas. J Gastrointest Surg 2023; 27 (07) 1445-1453
    CrossrefPubMedGoogle Scholar
  • 63 Jarrar A, Church J. Advancement flap repair: a good option for complex anorectal fistulas. Dis Colon Rectum 2011; 54 (12) 1537-1541
    CrossrefPubMedGoogle Scholar
  • 64 Sher ME, Bauer JJ, Gelernt I. Surgical repair of rectovaginal fistulas in patients with Crohn's disease: transvaginal approach. Dis Colon Rectum 1991; 34 (08) 641-648
    CrossrefPubMedGoogle Scholar
  • 65 Pitel S, Lefevre JH, Parc Y, Chafai N, Shields C, Tiret E. Martius advancement flap for low rectovaginal fistula: short- and long-term results. Colorectal Dis 2011; 13 (06) e112-e115
    CrossrefPubMedGoogle Scholar
  • 66 Songne K, Scotté M, Lubrano J. et al. Treatment of anovaginal or rectovaginal fistulas with modified Martius graft. Colorectal Dis 2007; 9 (07) 653-656
    CrossrefPubMedGoogle Scholar
  • 67 Wexner SD, Ruiz DE, Genua J, Nogueras JJ, Weiss EG, Zmora O. Gracilis muscle interposition for the treatment of rectourethral, rectovaginal, and pouch-vaginal fistulas: results in 53 patients. Ann Surg 2008; 248 (01) 39-43
    CrossrefPubMedGoogle Scholar
  • 68 Ulrich D, Roos J, Jakse G, Pallua N. Gracilis muscle interposition for the treatment of recto-urethral and rectovaginal fistulas: a retrospective analysis of 35 cases. J Plast Reconstr Aesthet Surg 2009; 62 (03) 352-356
    CrossrefPubMedGoogle Scholar
  • 69 Fürst A, Schmidbauer C, Swol-Ben J, Iesalnieks I, Schwandner O, Agha A. Gracilis transposition for repair of recurrent anovaginal and rectovaginal fistulas in Crohn's disease. Int J Colorectal Dis 2008; 23 (04) 349-353
    CrossrefPubMedGoogle Scholar
  • 70 Lefèvre JH, Bretagnol F, Maggiori L, Alves A, Ferron M, Panis Y. Operative results and quality of life after gracilis muscle transposition for recurrent rectovaginal fistula. Dis Colon Rectum 2009; 52 (07) 1290-1295
    CrossrefPubMedGoogle Scholar
  • 71 Picciariello A, Papagni V, De Fazio M. et al. Functional outcome and quality of life evaluation of graciloplasty for the treatment of complex recto-vaginal and recto-urethral fistulas. Updates Surg 2020; 72 (01) 205-211
    CrossrefPubMedGoogle Scholar
  • 72 Corte H, Maggiori L, Treton X, Lefevre JH, Ferron M, Panis Y. Rectovaginal Fistula: What is the optimal strategy? An analysis of 79 patients undergoing 286 procedures. Ann Surg 2015; 262 (05) 855-860 , discussion 860–861
    CrossrefPubMedGoogle Scholar
  • 73 Galandiuk S, Kimberling J, Al-Mishlab TG, Stromberg AJ. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg 2005; 241 (05) 796-801 , discussion 801–802
    CrossrefPubMedGoogle Scholar
  • 74 Guillem JG, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC, Schoetz Jr DJ. Factors predictive of persistent or recurrent Crohn's disease in excluded rectal segments. Dis Colon Rectum 1992; 35 (08) 768-772
    CrossrefPubMedGoogle Scholar
  • 75 Zeitels JR, Fiddian-Green RG, Dent TL. Intersphincteric proctectomy. Surgery 1984; 96 (04) 617-623
    PubMedGoogle Scholar
  • 76 Touny A, Othman H, Maamoon S, Ramzy S, Elmarakby H. Perineal reconstruction using pedicled vertical rectus abdominis myocutaneous flap (VRAM). J Surg Oncol 2014; 110 (06) 752-757
    CrossrefPubMedGoogle Scholar
  • 77 Johnstone MS. Vertical rectus abdominis myocutaneous versus alternative flaps for perineal repair after abdominoperineal excision of the rectum in the era of laparoscopic surgery. Ann Plast Surg 2017; 79 (01) 101-106
    CrossrefPubMedGoogle Scholar
  • 78 Tiernan JP, Leavitt T, Sapci I. et al. A comparison of perineal myocutaneous flaps following abdominoperineal excision of the rectum for anorectal pathology. Dis Colon Rectum 2022; 65 (11) 1316-1324
    CrossrefPubMedGoogle Scholar
  • 79 de Buck van Overstraeten A, Wolthuis AM, Vermeire S. et al. Intersphincteric proctectomy with end-colostomy for anorectal Crohn's disease results in early and severe proximal colonic recurrence. J Crohn's Colitis 2013; 7 (06) e227-e231
    CrossrefPubMedGoogle Scholar
  • 80 Corman ML, Veidenheimer MC, Coller JA, Ross VH. Perineal wound healing after proctectomy for inflammatory bowel disease. Dis Colon Rectum 1978; 21 (03) 155-159
    CrossrefPubMedGoogle Scholar
  • 81 Baudot P, Keighley MR, Alexander-Williams J. Perineal wound healing after proctectomy for carcinoma and inflammatory disease. Br J Surg 1980; 67 (04) 275-276
    CrossrefPubMedGoogle Scholar
  • 82 Yamamoto T, Bain IM, Allan RN, Keighley MR. Persistent perineal sinus after proctocolectomy for Crohn's disease. Dis Colon Rectum 1999; 42 (01) 96-101
    CrossrefPubMedGoogle Scholar
  • 83 Li W, Stocchi L, Elagili F, Kiran RP, Strong SA. Healing of the perineal wound after proctectomy in Crohn's disease patients: only preoperative perineal sepsis predicts poor outcome. Tech Coloproctol 2017; 21 (09) 715-720
    CrossrefPubMedGoogle Scholar
  • 84 Bertucci Zoccali M, Biondi A, Krane M. et al. Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy. Int J Colorectal Dis 2015; 30 (01) 87-95
    CrossrefPubMedGoogle Scholar
  • 85 Fujino S, Miyoshi N, Ohue M. et al. Use of Vacuum-assisted closure in management of open abdominal wound with multiple enterocutaneous fistulae during chemotherapy: a case report. Int J Surg Case Rep 2015; 17: 112-116
    CrossrefPubMedGoogle Scholar
  • 86 Meyer J, Roos E, Abbassi Z, Toso C, Ris F, Buchs NC. The role of perineal application of prophylactic negative-pressure wound therapy for prevention of wound-related complications after abdomino-perineal resection: a systematic review. Int J Colorectal Dis 2021; 36 (01) 19-26
    CrossrefPubMedGoogle Scholar
  • 87 McLeod RS, Palmer JA, Cohen Z. Management of chronic perineal sinuses by wide excision and split-thickness skin grafting. Can J Surg 1985; 28 (04) 315-316 , 318
    PubMedGoogle Scholar
  • 88 Kapoor V, Cole J, Isik FF, Sinanan M, Flum D. Does the use of a flap during abdominoperineal resection decrease pelvic wound morbidity?. Am Surg 2005; 71 (02) 117-122
    CrossrefPubMedGoogle Scholar
  • 89 Menon A, Clark MA, Shatari T, Keh C, Keighley MR. Pedicled flaps in the treatment of nonhealing perineal wounds. Colorectal Dis 2005; 7 (05) 441-444
    CrossrefPubMedGoogle Scholar
  • 90 Kamrava A, Mahmoud NN. Prevention and management of nonhealing perineal wounds. Clin Colon Rectal Surg 2013; 26 (02) 106-111
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 91 Hurwitz DJ, Zwiebel PC. Gluteal thigh flap repair of chronic perineal wounds. Am J Surg 1985; 150 (03) 386-391
    CrossrefPubMedGoogle Scholar